Illumina
Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. Illumina has developed a line of DNA sequencing technology products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests.
Illumina News
Illumina Launches Pilot Proteomics Study With UK Biobank, Inks Partnership With Nvidia
In collaboration with UK Biobank and pharma partners, Illumina will analyze 50,000 samples using the upcoming Protein Prep assay and NovaSeq X Plus platform.
Truveta Genome Project Launches With $320M Investment From Regeneron, Illumina, Health Systems
The initiative aims to generate genetic data on tens of millions of volunteers, creating the largest and most diverse database of genotypic and phenotypic information available.
Both short-read and long-read instrument makers are fleshing out their multiomics menus as they hope to gain a share of the fast-evolving market.
The past year was difficult for many life science tools companies but not all doom and gloom for some single-cell and spatial omics firms.
Illumina, Ovation Collaborate on Generating Clinical Genomic Data for Research
During the first phase, the partners will create pilot datasets for liver disease, chronic kidney disease, and patients treated with GLP-1 receptor agonists.